Christopher Brey

Christopher Brey is a seasoned professional specializing in facilities management and environmental health and safety (EH&S) with extensive experience in diverse industries. Currently serving as Senior Director of Facilities and EH&S at Cytokinetics since September 2017, Brey has previously held leadership roles at Ardelyx, Inc., Groupon, Elan Pharmaceuticals, and the Jewish Home of San Francisco, showcasing a strong track record in managing complex facilities operations, overseeing site closures, and enhancing sustainability practices. Notable achievements include architecting a 5-Year Environmental Sustainability Plan at Gilead Sciences and managing significant growth at CV Therapeutics from 70 to 700 employees. Brey holds an M.S. in Environmental Management from the University of San Francisco and a B.S. in Fisheries Biology from Humboldt State University.